Revolution Medicines, Inc 10-Q for FY2020 Q3
Revolution Medicines, Inc. (RVMD)
10-Q
2020-11-12
For: 2020-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Revolution Medicines, Inc filed this 10-Q on November 12, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).
Headline figures
Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $12.66M
- up 1.2% from $12.51M a year earlier
- Net loss
- $27.22M
- compared with a net loss of $12.82M a year earlier